Adv Exp Med Biol

1. MAKRYGIANNI P, Polikandrioti M, Koutelekos I, Tsiampouris I, et al
   Anxiety and Depression in Patients with Colorectal Cancer Undergoing Ileostomy: A Systematic Review.
   Adv Exp Med Biol. 2026;1487:493-501.
   

   >> Share

   
   

   
   BMC Cancer

2. YANG Q, Hu Y, Liu F
   Secular trend of colorectal cancer related with low physical activity from 1990 to 2021 in China.
   BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15290.
   

   >> Share

   
   
3. XIE HB, Zhang BB, Zhao L, Liu L, et al
   Prealbumin predicts metachronous liver metastasis in colorectal cancer.
   BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15296.
   

   >> Share

   
   
4. WANG L, Wu H, Chen Y, Wang G, et al
   Single-cell RNA sequencing reveals neutrophil differentiation-related genes for immunotherapy response prediction in colorectal cancer.
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15355.
   

   >> Share

   
   
5. LI K, Zhang R, Zhang J, Zhang Z, et al
   The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis.
   BMC Cancer. 2025;25:1822.
   

   >> Share

   
   
6. JIN X, Bai B, Pan Y, Xie S, et al
   Distinct clinical features and epidemiological trends of very early and middle-aged early onset colorectal cancer based on SEER 17 and GBD 2021 data over the past 15 years.
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15263.
   

   >> Share

   
   
7. PASSARDI A, Sullo FG, Bittoni A, Matteucci L, et al
   CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cance
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15371.
   

   >> Share

   
   

   
   BMC Gastroenterol

8. YU H, He Y, Lv T, Lu X, et al
   Prognostic value of the platelet-to-lymphocyte ratio in colorectal cancer patients undergoing chemotherapy: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025;25:834.
   

   >> Share

   
   
9. CHENG S, Chen L, Liu S, Zhang H, et al
   Association of lifestyle and dietary preferences with precancerous serrated polyps: a hospital-based case-control study in Guangzhou, China.
   BMC Gastroenterol. 2025;25:837.
   

   >> Share

   
   
10. BOUBACAR E, Balaraba ABA, Idrissa B, Mahamadou AA, et al
    Colorectal cancer in young: a 5-year study from a sub-Saharan African country.
    BMC Gastroenterol. 2025;25:844.
    

    >> Share

    
    
11. CHEN S, Wen M, Lv F, Yan L, et al
    Diagnostic value of Gd-EOB-DTPA-enhanced MRI versus contrast-enhanced CT for detecting liver metastasis in colorectal cancer: a systematic review and meta-analysis.
    BMC Gastroenterol. 2025 Nov 27. doi: 10.1186/s12876-025-04509.
    

    >> Share

    
    

    
    Br J Cancer

12. LEE HJ, Lee JH, Kang J, Kim K, et al
    Single-cell multiomic modelling of early metastatic events promoted by the extracellular matrix.
    Br J Cancer. 2025;133:1708-1719.
    

    >> Share

    
    

    
    Cancer

13. MYERS S, Davis ES, Franks JA, Davids JS, et al
    Beyond composite measures of regional vulnerability: Rural-urban colorectal cancer mortality disparities mediated by area-level characteristics.
    Cancer. 2025;131:e70098.
    

    >> Share

    
    

    
    Cancer Lett

14. ERMINE K, Chen D, Hao S, Liu Z, et al
    Reactivating necroptosis in colorectal cancer potentiates chemotherapy and antitumor immune responses.
    Cancer Lett. 2025 Nov 26:218169. doi: 10.1016/j.canlet.2025.218169.
    

    >> Share

    
    
15. TANG W, Lv Y, Xie H, Wei Y, et al
    Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer.
    Cancer Lett. 2026;636:218006.
    

    >> Share

    
    

    
    Dis Colon Rectum

16. ISHIZAKI T, Nagakawa Y, Yokozuka K, Kobayashi T, et al
    Robotic Management of Recurrent Peritoneal Colon Cancer.
    Dis Colon Rectum. 2025 Nov 25. doi: 10.1097/DCR.0000000000004025.
    

    >> Share

    
    

    
    Eur J Cancer

17. WERF-'T LAM AV, Dowty JG, Italia M, Bakker AC, et al
    Cancer risks for MSH6 pathogenic variant carriers.
    Eur J Cancer. 2025;231:116098.
    

    >> Share

    
    
18. VANDE KERCKHOVE FEC, van den Berg K, van Erning FN, Daniels-Gooszen AW, et al
    Implications of inaccurate lymph node staging in early and intermediate-risk rectal cancer on survival-related outcomes in a large Dutch population-based cohort.
    Eur J Cancer. 2025;231:116052.
    

    >> Share

    
    

    
    Eur J Surg Oncol

19. DE GRAAFF MR, Kok NFM, Grunhagen DJ, Nielen M, et al
    Influence of socioeconomic position on surgical outcomes after resection of colorectal liver metastases.
    Eur J Surg Oncol. 2025;51:110459.
    

    >> Share

    
    
20. STICCA G, Soucisse M, Abou-Khalil M, Gervais MK, et al
    Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastases.
    Eur J Surg Oncol. 2025;51:110534.
    

    >> Share

    
    
21. ALTINSOY E, Ozcan VC, Zeynalov H, Cebeci? E, et al
    An onco-vascular surgical approach: Internal iliac artery transposition for external iliac artery repair during cytoreductive surgery.
    Eur J Surg Oncol. 2025;51:110503.
    

    >> Share

    
    
22. VAN DEN HEUVEL TBM, van Erning FN, Hemmer PHJ, Madsen EVE, et al
    Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases: Insights from the Dutch CRS-HIPEC registry.
    Eur J Surg Oncol. 2025;51:110501.
    

    >> Share

    
    
23. CHATZIPANAGIOTOU OP, Kawashima J, Baldo A, Ruzzenente A, et al
    Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified tumor burden score.
    Eur J Surg Oncol. 2025;51:110527.
    

    >> Share

    
    

    
    Gastrointest Endosc

24. SOOD A, Herman N, Hung CK
    Safety of Endoscopy Following Recent Bevacizumab Use in Metastatic Colorectal Cancer.
    Gastrointest Endosc. 2025 Nov 20:S0016-5107(25)02201.
    

    >> Share

    
    

    
    Gut

25. GRANCHER A, Denis B, Plaine J, Vidal-Sengchanh S, et al
    Does a long time to colonoscopy after a positive faecal immunochemical test result have a deleterious impact on colorectal cancer outcomes? A nationwide cohort study.
    Gut. 2025 Nov 27:gutjnl-2025-336036. doi: 10.1136/gutjnl-2025-336036.
    

    >> Share

    
    

    
    Int J Cancer

26. HJORTH CF, Olsen MH, Ulrichsen SP, Nors J, et al
    Body mass index and colorectal cancer recurrence and mortality: A nationwide cohort study in Denmark.
    Int J Cancer. 2025 Nov 21. doi: 10.1002/ijc.70248.
    

    >> Share

    
    

    
    J Surg Oncol

27. GOULD LE, Pring ET, Drami I, Constantinides J, et al
    Gluteal Flap Reconstruction Following Complex Rectal Cancer Surgery: A Large Consecutive Series of Perineal Wounds Exploring Risk Factors for Complications.
    J Surg Oncol. 2025;132:1399-1406.
    

    >> Share

    
    
28. AL DHAHERI M, Mubarak R, Toffaha A, AbuNada M, et al
    Organ Preserving or Radical Surgery? A Systematic Review and Meta-Analysis of Transanal Local Excision Versus Total Mesorectal Excision After Neoadjuvant Therapy for Rectal Cancer.
    J Surg Oncol. 2025;132:1337-1355.
    

    >> Share

    
    
29. CENGIZ F, Gunay S, Vatansever S, Kiziltoprak N, et al
    Functional Outcomes After Rectal ESD: A Retrospective Evaluation of Low Anterior Resection Syndrome.
    J Surg Oncol. 2025;132:1331-1336.
    

    >> Share

    
    
30. EMILE SH, Horesh N, Garoufalia Z, Oosenbrug M, et al
    A Seer-Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas.
    J Surg Oncol. 2025;132:1320-1330.
    

    >> Share

    
    
31. LE V, Franko J, Fong Y
    Complete Cytoreduction of Colorectal Liver Metastases: Evolving Systemic Therapy and Liver Transplantation.
    J Surg Oncol. 2025;132:1317-1319.
    

    >> Share

    
    

    
    Lancet Oncol

32. AMATU A, Patelli G, Zampino MG, Bergamo F, et al
    Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.
    Lancet Oncol. 2025;26:1612-1625.
    

    >> Share

    
    
33. KIM S, Boustani J, Iseas S, Vernerey D, et al
    Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial.
    Lancet Oncol. 2025;26:1626-1637.
    

    >> Share

    
    

    
    N Engl J Med

34. GUO Q, Zhao Y, Yin C
    Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.
    N Engl J Med. 2025;393:2173.
    

    >> Share

    
    
35. MARTLING A, Myrberg IH, Lindberg J
    Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer. Reply.
    N Engl J Med. 2025;393:2173.
    

    >> Share

    
    

    
    Oncogene

36. LV M, Hu C, Li J, Zhang Y, et al
    Serotonin receptor type 7 (5-HT7) promotes colorectal cancer progression by activating Wnt/beta-catenin signaling via interacting with CK1epsilon.
    Oncogene. 2025 Nov 26. doi: 10.1038/s41388-025-03645.
    

    >> Share

    
    

    
    PLoS Med

37. XIE J, Dong X, Luo Z, Wang C, et al
    The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study.
    PLoS Med. 2025;22:e1004807.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share